Galantamine Smoking Study

Diseases and Conditions Researched

Nicotine Dependence

What is the purpose of this trial?

You are invited to participate in a research study at the VA Connecticut Healthcare System (West Haven campus) that examines whether a medication called galantamine can improve your learning and memory, and also help you to quit smoking. You have been invited to participate because you currently smoke cigarettes, and want to quit smoking. If you are eligible and agree to be in the study, your participation will last for approximately 8 weeks. To determine if galantamine (8 or 16 mg) is superior to placebo a) in reducing smoking self-administration in a human laboratory model and b) improving abstinence rates at the end of 4 weeks of treatment.

Participation Guidelines

Age: 18 Years - 55 Years
Gender: Both

Click here for detailed participation information for this trial.

Sponsor: National Institute on Drug Abuse
Last Updated:
Study HIC#: 1306012154